ResearcherTUM KlinikumNo recent work listed

Benedikt K. Kaufmann

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8141-9676; OpenAlex author ID A5059928385. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2019: 1 paper

Papers 1

Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1159/000493466 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Helmut Frieß · 1 shared paper, 2019 · strength 0.11
- Paper Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.1159/000493466 ↗
Jan Goesta D’Haese · 1 shared paper, 2019 · strength 0.11
- Paper Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.1159/000493466 ↗
Beat Gloor · 1 shared paper, 2019 · strength 0.11
- Paper Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.1159/000493466 ↗
Pavel Stupakov · 1 shared paper, 2019 · strength 0.11
- Paper Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.1159/000493466 ↗
Dejan V. Radenkovic · 1 shared paper, 2019 · strength 0.11
- Paper Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.1159/000493466 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.